Working… Menu

Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00004039
Recruitment Status : Withdrawn (No patient accruals)
First Posted : August 5, 2004
Last Update Posted : August 19, 2015
Cancer Biotherapy Research Group
Information provided by:
Hoag Memorial Hospital Presbyterian

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : January 2000
Actual Study Completion Date : January 2000